BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  K2 Medical Research Appoints Robert Massey as Chief Commercial Officer in Newly Created Role, Signaling Next Chapter of Growth

  September 15, 2026

   · 

  4 min read
• Press Releases

  Nix Biosensors Closes Series A to Bring Hydration Data to Consumer Health Platforms

  September 15, 2026

   · 

  3 min read
• 

  Regulatory

  FDA opens Operation TrialBlazer for applications, hoping to reshore early trials

  The FDA aims to leverage the expertise of qualified research institutions paired with drug sponsors to lessen the risk of clinical holds during the investigational new drug review process and expedite the path to first-in-human development in the U.S. The initial application period will close on Oct. 30.

  September 15, 2026

   · 

  1 min read

   · 

  Heather McKenzie
• Press Releases

  FDA Launches Expedited IND Pilot, Begins Accepting Applications

  September 15, 2026

   · 

  4 min read
• Press Releases

  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - September 15, 2026

  September 15, 2026

   · 

  3 min read
• Press Releases

  Biotle Reports Encouraging Initial Phase 1/2 Clinical Activity for BTL-101 in Relapsed/Refractory Multiple Myeloma

  Disease control observed in all three patients at the first and lowest dose level, supporting continued dose escalation

  September 15, 2026

   · 

  1 min read
• Press Releases

  Ractigen Therapeutics to Present First-in-Human RNA Activation Data in Duchenne Muscular Dystrophy as a Late-Breaking Oral Presentation at the 31st Annual Congress of the World Muscle Society

  September 15, 2026

   · 

  5 min read
• Press Releases

  Malvern Panalytical launches Zetasizer Core – an industry first in biologics plate-based stability screening

  September 15, 2026

   · 

  5 min read
• Press Releases

  NEW JAMA NETWORK OPEN STUDY SHOWS GIVING LESS IV FLUIDS DURING SURGERY CAN BE BENEFICIAL FOR PATIENTS

  September 15, 2026

   · 

  3 min read
• Press Releases

  Thryv Therapeutics Announces JACC: Heart Failure Publication of Converging Human Genetic, Preclinical, and Clinical Evidence Supporting Phase 2a Development of Lead SGK1 Inhibitor THRV-1268 in Heart Failure

  September 15, 2026

   · 

  5 min read